Xoma (XOMA) - Antibody Manufacturing Pilot Plant and Capabilities
HEALTHCARE | Biotechnology
See what CB Insights has to offer
Acquired Unit | Acquired
About Xoma (XOMA) - Antibody Manufacturing Pilot Plant and Capabilities
XOMA (NASDAQ: XOMA) is a biotechnology company focused on the discovery and development of monoclonal antibody-based therapeutics. The Company is a late-stage biotechnology company with a diverse portfolio of innovative therapeutic antibodies. XOMA's innovative product candidates are the result of its expertise in developing ground-breaking monoclonal antibodies, which have created new opportunities to potentially treat a wide range of endocrine diseases.
Xoma (XOMA) - Antibody Manufacturing Pilot Plant and Capabilities Headquarter Location
2910 Seventh Street
Berkeley, California, 94710,
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing Xoma (XOMA) - Antibody Manufacturing Pilot Plant and Capabilities
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Xoma (XOMA) - Antibody Manufacturing Pilot Plant and Capabilities is included in 2 Expert Collections, including Pharma Startups.
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.